Paul, Weiss, Rifkind, Wharton & Garrison LLP

Paul, Weiss, Rifkind, Wharton & Garrison LLP's M&A disputes practice has a proven track record of supporting clients in various transaction-related disputes, including M&A counterpart disputes, SPAC and de-SPAC defense, controller and special committee disputes, earn-out and valuation disputes, and strategic counseling. The team is also adept at handling cases in the Delaware Court of Chancery. Spearheading the practice from New York are Andrew Gordon, who handles high-stakes deal termination litigation, including defending Edwards Lifesciences in breach of contract litigation, and Jaren Janghorbani, a commercial litigator and trial lawyer who advised Metsera in litigation related to the acquisition of Pfizer. Geoff Chepiga, deputy chair, is well-versed in high-stakes transaction-related disputes and advised Sketchers USA in a multitude of appraisal actions arising from the acquisition of 3G Capital. Other key names include Wilmington-based Andre Bouchard, who is particularly focused on disputes in the Delaware Court of Chancery, and Daniel Mason, who handles a full range of corporate and commercial litigation involving fiduciary duties of directors and controlling stockholders.